Miguel St-Onge

Person

Vaudreuil-Dorion, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway
- Patent number 10,030,024
- Issue date Jul 24, 2018
- Vertex Pharmaceuticals Incorporated
- Luc J. Farmer
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC COMPOUNDS AND USES THEREOF
- Publication number 20250002487
- Publication date Jan 2, 2025
- Ventus Therapeutics U.S., Inc.
- Ramsay Beveridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240368160
- Publication date Nov 7, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240368131
- Publication date Nov 7, 2024
- VENTUS THERAPEUTICS U.S. INC.
- Stéphane Dorich
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240360128
- Publication date Oct 31, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
- Publication number 20240360129
- Publication date Oct 31, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
- Publication number 20240199606
- Publication date Jun 20, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3
- Publication number 20240174668
- Publication date May 30, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20240158396
- Publication date May 16, 2024
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
- Publication number 20240018138
- Publication date Jan 18, 2024
- Ventus Therapeutics U.S., Inc.
- Lee Fader
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20230159526
- Publication date May 25, 2023
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF
- Publication number 20220340567
- Publication date Oct 27, 2022
- Ventus Therapeutics U.S., Inc.
- Stéphane DORICH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS
- Publication number 20220185809
- Publication date Jun 16, 2022
- Repare Therapeutics Inc.
- Sheldon N. Crane
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING CO...
- Publication number 20210277002
- Publication date Sep 9, 2021
- Repare Therapeutics Inc.
- Sheldon N. CRANE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDAZINES USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY
- Publication number 20190119282
- Publication date Apr 25, 2019
- VERTEX PHARMACEUTICALS INCORPORATED
- Luc J. Farmer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIG...
- Publication number 20180057505
- Publication date Mar 1, 2018
- VERTEX PHARMACEUTICALS INCORPORATED
- Camil Elie SAYEGH
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOPYRIDAZINES USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY
- Publication number 20160311825
- Publication date Oct 27, 2016
- VERTEX PHARMACEUTICALS INCORPORATED
- Luc J. Farmer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
- Publication number 20130296382
- Publication date Nov 7, 2013
- Jason Burch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS
- Publication number 20110245296
- Publication date Oct 6, 2011
- Jason Burch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Miguel St-Onge

Person

Patents Grantslast 30 patents

Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway

Patents Applicationslast 30 patents

HETEROCYCLIC COMPOUNDS AND USES THEREOF

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

OXOINDOLINYL AMIDE DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

PYRIDAZINE COMPOUNDS FOR INHIBITING NLRP3

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

PYRIDO[4,3-b]INDOLE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

COMPOUNDS FOR INHIBITING NLRP3 AND USES THEREOF

SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS

COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING CO...

IMIDAZOPYRIDAZINES USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY

BICYCLIC HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF THE PAR-2 SIG...

IMIDAZOPYRIDAZINES USEFUL AS INHIBITORS OF THE PAR-2 SIGNALING PATHWAY

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS

NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS